UCSF Spinout Calithera Biosciences Takes $40 Million First Round
The cancer-fighting drug researcher is developing methods of activating caspases, enzymes that induce programmed cell death.
The cancer-fighting drug researcher is developing methods of activating caspases, enzymes that induce programmed cell death.